Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
Buy Reports For This Company

OSI Pharmaceuticals, Inc.
MelvilleNY United States
  (NASDAQ: OSIP)

btn-overview-2btn-people-1btn-competition-1btn-financials-1

Company Description

Fighting disease in small ways is what OSI Pharmaceuticals is all about. The company focuses on small molecule cures for diseases like cancer, allowing for treatment by pill rather than IV infusion. Its top seller Tarceva treats non-small cell lung cancer and pancreatic cancer and is in development for other indications as well. Partner Genentech co-promotes the drug in the US, and it is marketed internationally by Roche. OSI also has a pipeline of drug candidates focused on new anti-cancer compounds. UK subsidiary Prosidion manages the company's small-molecule patents for diabetes and obesity treatments. OSI was acquired by Japanese drugmaker Astellas Pharma for $4 billion in 2010.

41 Pinelawn Rd.Phone: 631-962-2000http://www.osip.com
MelvilleNY 11747Fax: 631-752-3880Map Map This Company
United States

Try a Full Premium Subscription

Access over 85 million companies
Call (866) 443-3939 or

btn-free-trial

Prepare for your Sales call

Try a Small Business Subscription
Starting $89 per month

btn-subscribe-now

OSI Pharmaceuticals, Inc. Rankings

Executives

29 executives listed for OSI Pharmaceuticals, Inc.'s Melville, NY location.
ChairmanRobert IngramE-mail
EVP, CFO, and TreasurerPierre LegaultE-mail
EVP Pharmaceutical Development and ManufacturingRobertSimonE-mail

More OSI Pharmaceuticals, Inc. Executives

Financials

Company TypeSubsidiary - NASDAQ: OSIP Headquarters
Fiscal Year-EndDecember
Employees535
More OSI Pharmaceuticals, Inc. Financials
D&B logoDNBi

Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on OSI Pharmaceuticals, Inc. now.

  • Reduce risk.
  • Drive greater profitability.
  • Increase cash flow.
Get a Credit Report Now

Sponsored Links